New asthma drug tezepelumab put to the test in Real-Life greek clinics
NCT ID NCT06724575
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This study follows 155 people with severe asthma who are starting a new medicine called tezepelumab. Researchers want to see how well it controls asthma symptoms and improves quality of life over two years in real-world clinics across Greece. The goal is to understand if this treatment works as well outside of strict trial settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alexandroupoli, Greece
-
Research Site
Athens, Greece
-
Research Site
Corfu, Greece
-
Research Site
Crete, Greece
-
Research Site
Ioannina, Greece
-
Research Site
Larissa, Greece
-
Research Site
Pátrai, Greece
-
Research Site
Thessaloniki, Greece
Conditions
Explore the condition pages connected to this study.